Skip to main content
ASBH 2023 Annual Conference Main banner
Georgetown Nursing PhD Ad
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Gail A. Edelsohn, MD, MSPH, MBE (she/her/hers)

Senior Medical Director, Quality
Community Care Behavioral Health Organization, UPMC Insurance Services Division
Huntingdon Valley, Pennsylvania

Gail Edelsohn, MD, MSPH, MBE, CHCQM (she, her, hers) is a Senior Medical Director, Quality, Community Care Behavioral Health Organization, UPMC Insurance Services. In that role she provides medical leadership to address systemic safety and quality of care concerns across the network. She works to advance total quality management through collaboration and communication within Community Care and externally with providers, primary contractors and stakeholders. She has a longstanding commitment advocating for quality of care for the treatment of mental illness and substance use disorders in the public sector. Dr. Edelsohn graduated from the Lewis Katz Temple University School of Medicine, completed general Psychiatry and Child and Adolescent Psychiatry residencies, Preventive Medicine fellowship, and a Master of Science in Public Health at the University of North Carolina, Chapel Hill and Master in Bioethics at the University of Pennsylvania, Pearlman School of Medicine.

Prior to joining Community Care in 2011, Dr. Edelsohn served as Associate Medical Director, Children’s Services, Philadelphia Department of Behavioral Health and Intellectual Disabilities. She previously held the position of Division Chief, Child and Adolescent Psychiatry, Thomas Jefferson University, and held joint faculty appointments at Johns Hopkins School of Medicine and Bloomberg School of Public Health. Dr. Edelsohn is a member and past co-chair of the American Academy of Child and Adolescent Psychiatry (AACAP) Ethics Committee, American Psychiatric Association, distinguished fellow, served as past president of the Pennsylvania Psychiatric Society and is a member of American Society of Bioethics and Humanities. Her publications have examined factors related to psychotropic medication utilization in Medicaid enrolled youth and ethical issues in child and adolescent psychiatry, and ethical issues regarding psychedelic research and treatment of youth.

Disclosure(s): No financial relationships to disclose

Presentation(s):